Skip to main content

Please enter a keyword and click the arrow to search the site

Centrafarm Group NV (A)


Economics, Entrepreneurship

Publication Year



"Stock markets around the world are in free-fall tonight... On Wall Street shares have plunged by a third." Monday 19th October 1987, Bryan Wood, Managing Director of Alta Berkeley Associates, a London based international venture capital firm, sat amazed in front of the television as he watched the story of the day's events. Over the next few days the carnage on the world's financial markets continued. The week before he had been planning to look for a trade buyer for Centrafarm Group N.V., a Benelux-based pharmaceutical company quoted on NASDAQ National Market System in the US, in which he and two other investors had a major stake. Then the shares had been trading at over $15; they now stood below $7. The search for a buyer was placed on hold while the chaos died down. However, by late 1987, there had been little improvement in the price even though, on the face of it, the company's prospects were little changed by recent events. Wood and the other members of the investment syndicate arranged a meeting. Where did they go from here?

Topic List

Entreprenuership, Financing, Growth, Exit, Valuation, Venture Capital



Publication Event Date


LBS Case Number




Publication Research Centre




Available on ECCH


Select up to 4 programmes to compare

Select one more to compare
subscribe_image_desktop 5949B9BFE33243D782D1C7A17E3345D0

Sign up to receive our latest news and business thinking direct to your inbox


Sign up to receive our latest course information and business thinking

Leave your details above if you would like to receive emails containing the latest thought leadership, invitations to events and news about courses that could enhance your career. If you would prefer not to receive our emails, you can still access the case study by clicking the button below. You can opt-out of receiving our emails at any time by visiting: or by unsubscribing through the link provided in our emails. View our Privacy Policy for more information on your rights.